投稿咨詢
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.
The subject material appropriate for submission includes:
? Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
? Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
? Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
? Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
? Agents that activate genes or modify transcription and translation within the immune response.
? Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
? Production, function and regulation of cytokines and their receptors.
? Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
《International Immunopharmacology》是一本由ELSEVIER出版商出版的專業醫學期刊，該刊創刊于2001年，刊期Monthly，該刊已被國際權威數據庫SCI、SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 2區，小類學科：藥學 2區；免疫學 3區；在JCR（Journal Citation Reports）分區等級為Q1。該刊發文范圍涵蓋免疫學等領域，旨在及時、準確、全面地報道國內外免疫學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為5.714，平均審稿速度約2.7個月。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 醫學 | 2區 | PHARMACOLOGY & PHARMACY 藥學 IMMUNOLOGY 免疫學 | 2區 3區 | 否 | 否 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q1 | PHARMACOLOGY & PHARMACY | Q1 | 5.714 |
| IMMUNOLOGY | Q2 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 5.714 | 98 | 7.25% | 88.27% | 未開放 | 約2.7個月 |
課題、SCI/EI/SSCI怎么寫？